Page last updated: 2024-11-04

sulfasalazine and Carcinoma, Oat Cell

sulfasalazine has been researched along with Carcinoma, Oat Cell in 2 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guan, J1
Lo, M1
Dockery, P1
Mahon, S1
Karp, CM1
Buckley, AR1
Lam, S1
Gout, PW1
Wang, YZ1
Awasthi, S1
Sharma, R1
Singhal, SS1
Herzog, NK1
Chaubey, M1
Awasthi, YC1

Other Studies

2 other studies available for sulfasalazine and Carcinoma, Oat Cell

ArticleYear
The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
    Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:3

    Topics: Amino Acid Transport System y+; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transpo

2009
Modulation of cisplatin cytotoxicity by sulphasalazine.
    British journal of cancer, 1994, Volume: 70, Issue:2

    Topics: Carcinoma, Small Cell; Cisplatin; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism;

1994